Abstract

[1- 14C]Acetate, [1- 14C]propionate and [1- 14C]butyrate were administered to sheep and goats via the jugular vein, portal vein or added directly into the rumen in order to study the effect of route of administration on transfer of 14C to liver glycogen and various blood substrates. The data show that the extent to which 14C from [1- 14C]-acetate, [1- 14C]propionate or [1- 14C]butyrate is incorporated into blood glucose or liver glycogen depends on whether the acids are injected into the jugular vein or portal vein or added to the rumen. The work demonstrates that a tracer dose of [ 14C]butyrate injected into the jugular vein labels blood glucose more than [ 14C]acetate because of the higher specific activity of blood butyrate. When unlabeled butyrate is administered along with a tracer dose of [1- 14C]butyrate the specific activity of blood glucose is similar to that observed when acetate is administered. This glucogenic effect of butyrate that has been observed many times is an anomaly and is explained by the fact that a tracer dose of [1- 14C]butyrate injected into the jugular vein is not diluted with unlabeled butyrate because butyrate is not normally present in peripheral blood.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.